dc.contributor.author | AbdelRazek, Mahmoud A. | |
dc.contributor.author | Marey, Ahmed | |
dc.contributor.author | Taha, Ahmed | |
dc.contributor.author | Morin, Scott J. | |
dc.contributor.author | Brodski, Alexander | |
dc.contributor.author | Mollashahi, Roohallah S. | |
dc.date.accessioned | 2023-09-27T18:25:31Z | |
dc.date.available | 2023-09-27T18:25:31Z | |
dc.date.issued | 2023-08-24 | |
dc.identifier.uri | https://hdl.handle.net/1721.1/152269 | |
dc.description.abstract | Abstract
Background
Lance–Adams syndrome (LAS), also known as chronic post-hypoxic myoclonus manifests as myoclonic movements of the face, limbs, or trunk following hypoxic brain injury, which may occur during respiratory failure or cardiac arrest.
Case presentation
We present a case and provide a video of a patient who developed LAS 3 years after experiencing cardiac arrest, presenting with action-induced generalized myoclonus upon standing. The patient exhibited a significant response to levetiracetam. To the best of our knowledge, this is the first reported case of LAS with such a delayed onset following the initial hypoxic event.
Conclusion
It is crucial for clinicians to be aware of this treatable condition and recognize that its onset may be delayed, occurring years after a hypoxic brain insult. This improved understanding will facilitate prompt diagnosis and effective management of LAS, ultimately enhancing patient outcomes. | en_US |
dc.publisher | Springer Berlin Heidelberg | en_US |
dc.relation.isversionof | https://doi.org/10.1186/s41983-023-00721-8 | en_US |
dc.rights | Creative Commons Attribution | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_US |
dc.source | Springer Berlin Heidelberg | en_US |
dc.title | Overnight response to levetiracetam in Lance–Adams syndrome presenting 3 years after cardiac arrest | en_US |
dc.type | Article | en_US |
dc.identifier.citation | The Egyptian Journal of Neurology, Psychiatry and Neurosurgery. 2023 Aug 24;59(1):120 | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Institute for Medical Engineering & Science | |
dc.identifier.mitlicense | PUBLISHER_CC | |
dc.eprint.version | Final published version | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dc.date.updated | 2023-08-27T03:12:06Z | |
dc.language.rfc3066 | en | |
dc.rights.holder | Egyptian Society of Neurology, Psychiatry, and Neurosurgery | |
dspace.embargo.terms | N | |
dspace.date.submission | 2023-08-27T03:12:06Z | |
mit.license | PUBLISHER_CC | |
mit.metadata.status | Authority Work and Publication Information Needed | en_US |